Five eye-openers from the MIT Healthcare Panel
This past October, I sat down with four transformational healthcare leaders at the MIT Museum in Cambridge, MA. The panel represented a mix of the three archetypes of Prophet’s Evolved Healthcare Enterprise: Transformers – mature, traditional healthcare companies seeking to better leverage modern approaches to growth, Invaders – well-established, fast growing non-healthcare organizations moving into the healthcare ecosystem. And Creators – next-generation healthcare companies built from the ground up. •Kelsey Yevak, Transformer: Sanofi is a “Transformer,” a long-established healthcare player, seeking t...
Source: EyeForPharma - November 28, 2019 Category: Pharmaceuticals Authors: Paul Schrimpf Source Type: news
Five eye-openers from the MIT Healthcare Panel
This past October, I sat down with four transformational healthcare leaders at the MIT Museum in Cambridge, MA. The panel represented a mix of the three archetypes of Prophet’s Evolved Healthcare Enterprise: Transformers – mature, traditional healthcare companies seeking to better leverage modern approaches to growth, Invaders – well-established, fast growing non-healthcare organizations moving into the healthcare ecosystem. And Creators – next-generation healthcare companies built from the ground up. •Kelsey Yevak, Transformer: Sanofo is a “Transformer,” a long-established healthcare player, seeking t...
Source: EyeForPharma - November 28, 2019 Category: Pharmaceuticals Authors: Paul Schrimpf Source Type: news
The online health trends pharma should be tapping into
Each year digital folk all over the world look to the Internet Trends report, delivered by Bond Capital founder Mary Meeker, for a summary of the most important emerging online technologies and consumer behaviours.
The 2019 report underlines the strength of some trends familiar to pharma and points to some unsettling implications for the industry if it cannot respond appropriately. Along with some general online trends - the growing consumption of images and video, the rise of the podcast and the ongoing spread of Amazon Echo - the report highlights some important consumer healthcare trends.
Perhaps the chief high...
Source: EyeForPharma - November 20, 2019 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news
The online health trends pharma should be tapping into
Each year digital folk all over the world look to the Internet Trends report, delivered by Bond Capital founder Mary Meeker, for a summary of the most important emerging online technologies and consumer behaviours.
The 2019 report underlines the strength of some trends familiar to pharma and points to some unsettling implications for the industry if it cannot respond appropriately. Along with some general online trends - the growing consumption of images and video, the rise of the podcast and the ongoing spread of Amazon Echo - the report highlights some important consumer healthcare trends.
Perhaps the chief high...
Source: EyeForPharma - November 20, 2019 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news
Taking the plunge into digital
There are so many opportunities for medical affairs to harness the potential of digital tools it ’s hard to know where to start.
Virtual meetings, cloud-based data sharing and mass intelligence gathering on patients and HCPs are some of the most obvious opportunities. Multiple online, social and other media meanwhile can transform the ability of medical affairs to help healthcare providers and patients find the information they need, when they need it, in the form they need it.
But these are early days, and it ’s hardly controversial to say that medical affairs is still generally only taking baby steps in digital...
Source: EyeForPharma - November 13, 2019 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news
Putting a Price on Life: Is the Answer Outside Pharma?
To cure the previously incurable we must take two giant steps: the first towards better understanding the science behind a cure, and the second towards ensuring accessibility for those people in need of the treatment. Although there is still much to discover, we got the science right some time ago. The first gene replacement therapy – Gendicine (Shenzhen SiBiono GeneTech) – was approved in China in 2003 and has been successfully administered to more than 30,000 patients with head and neck squamous cell carcinoma. A single dose of this medication costs $400. Another example of early innovation is Neovasculgen (...
Source: EyeForPharma - November 4, 2019 Category: Pharmaceuticals Authors: Nicola Davies Source Type: news
Breaking out of data silos in commercial
The healthcare business generates over a trillion gigabytes every year. That number is also known as one zettabyte –you may well want to get used to the higher order counts when it comes to data. This zettabyte count will double, Moore ’s Law style, every two years. This explosion of data should portend the best of times: Just think about the applications and algorithms that could run on all those datapoints and the insights and innovation they could deliver. The reality right now is somewhat more prosaic though. Most pharma companies are today drowning in data lakes, yet they continue to be relatively thirsty ...
Source: EyeForPharma - October 22, 2019 Category: Pharmaceuticals Authors: Ulrich Neumann Source Type: news
Breaking out of data silos in commercial
The healthcare business generates over a trillion gigabytes every year. That number is also known as one zettabyte –you may well want to get used to the higher order counts when it comes to data. This zettabyte count will double, Moore ’s Law style, every two years. This explosion of data should portend the best of times: Just think about the applications and algorithms that could run on all those datapoints and the insights and innovation they could deliver. The reality right now is somewhat more prosaic though. Most pharma companies are today drowning in data lakes, yet they continue to be relatively thirsty ...
Source: EyeForPharma - October 21, 2019 Category: Pharmaceuticals Authors: Ulrich Neumann Source Type: news
Free webinar: Deeper patient insights for stronger patient outcomes
Channels: Patients and MedicalImage: URL: https://www.eyeforpharma.com/barcelona/webinar/?partner=efp-website&utm_source=efp%20website&utm_medium=banner&utm_campaign=IQVIA%20webinarExclude from Homepage: No (Source: EyeForPharma)
Source: EyeForPharma - October 18, 2019 Category: Pharmaceuticals Authors: Izzy Gladstone Source Type: news
Empowering patients with the right data at the right time
We ’ve all read about the potential for data to transform healthcare by enabling patients to better understand their conditions and engage better in their treatment. Now a handful of pioneers are starting to demonstrate the potential and to justify some of the hype. Some rapid improvements in outcomes and adherence point the way to a future in which agile pharma teams routinely work with ever more real-time, real-world data to rapidly and iteratively improve patient insights and outcomes. In the era in which payments will increasingly be tied to results, such innovations should be of huge value, and will have the add...
Source: EyeForPharma - October 17, 2019 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news
Five Shifts Toward Consumer-Centric Transformation
In the 1990s American physician Tom Ferguson coined the concept of the “e-patient”. Ferguson, an advocate for increasing the role of the patient in managing their own healthcare, defined e-patients as empowered: engaged, equipped and enabled. The e-patient was a concept limited to direct interactions with healthcare organizations and at Prophet we have expanded the concept of the e-patient and evolved it into the ‘e-consumer’. If healthcare organizations are to serve the e-consumer and engage, empower, equip, and enable them, they will need to make a shift and put the consumer at the center of all they do. This ...
Source: EyeForPharma - October 14, 2019 Category: Pharmaceuticals Authors: Anonymous Source Type: news
Putting patients front and center
‘Access ' and ‘patient value’ are familiar terms in the pharma industry, but so often they are used in the abstract with little sense of what they mean to people at the receiving end of healthcare.
Liz Lewis, Head of Global Oncology Patient Value, Policy, and Access at Takeda Oncology, knows better than most, and knows what these words truly mean to people living with cancer around the globe.
Her experience started in childhood. While in high school, she spent time working in the office of her physician father, gaining an understanding of how the reimbursement process worked. Her father would often discuss the ...
Source: EyeForPharma - September 20, 2019 Category: Pharmaceuticals Authors: astone Source Type: news
Towards Patient Preferred Trials
The need to reform the clinical trials process with the patient in mind is becoming ever more apparent. Given the expense and time it takes to find and retain suitable trial candidates, making a trial scientifically rigorous is no longer enough. It must also be compatible with a patient ’s lifestyle.
Participants in clinical trials are not numbers on a spreadsheet. They are customers, consumers, patients and people with complexities, preferences and nuances. Increasingly they are demanding more choice and more involvement in their treatment journey.
New technology that enables pharma to digitise trials and make t...
Source: EyeForPharma - September 18, 2019 Category: Pharmaceuticals Authors: Katie Osborne Source Type: news
Design: Pharma ’s next frontier
Banking hadn ’t changed in decades before disruptive, challenger banks like Monzo gained cult status among customers for their ease of use. These challengers fulfilled needs people didn’t even know they had, but soon came to rely on – individually relatively small benefits such as choosing PINs, blocking l ost cards from an app or receiving geo-tagged purchase notifications – but collectively amounting to a very different experience.
What brings them together is the quality of thinking behind the consumer experience. Today, parts of pharma are adopting different user-centred design approaches to their products a...
Source: EyeForPharma - September 16, 2019 Category: Pharmaceuticals Authors: Lucy Fulford Source Type: news
The Jan Twomey story — Empowering and connecting
Earlier this year Jan had a big decision to make. In her early 60s, she could leave pharma and pursue her dream to join the crew on the Mercy ship – serving patients in need around Africa - or stay with Takeda through their transition and lead the Medical team for Oceania. She chose to stay and here’s why. “It gives me a lot of pleasure helping my team to be happy and thrive,” says Jan. Jan was raised to really think about society and people. Her father encouraged vigorous debate, pushing Jan to defend her beliefs and statements. As a child of the 70’s, Jan was on a mission to change the world and started by...
Source: EyeForPharma - September 6, 2019 Category: Pharmaceuticals Authors: Jill Donahue Source Type: news
